BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aourz N, Serruys AK, Chabwine JN, Balegamire PB, Afrikanova T, Edrada-Ebel R, Grey AI, Kamuhabwa AR, Walrave L, Esguerra CV, van Leuven F, de Witte PAM, Smolders I, Crawford AD. Identification of GSK-3 as a Potential Therapeutic Entry Point for Epilepsy. ACS Chem Neurosci 2019;10:1992-2003. [PMID: 30351911 DOI: 10.1021/acschemneuro.8b00281] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Birhan YS. Medicinal plants utilized in the management of epilepsy in Ethiopia: ethnobotany, pharmacology and phytochemistry. Chin Med 2022;17:129. [DOI: 10.1186/s13020-022-00686-5] [Reference Citation Analysis]
2 Hao Y, Ou Y, Zhang C, Chen H, Yue H, Yang Z, Zhong X, Hu W, Sun P. Seratrodast, a thromboxane A2 receptor antagonist, inhibits neuronal ferroptosis by promoting GPX4 expression and suppressing JNK phosphorylation. Brain Res 2022;1795:148073. [PMID: 36075466 DOI: 10.1016/j.brainres.2022.148073] [Reference Citation Analysis]
3 Hwang K, Vaknalli RN, Addo-osafo K, Vicente M, Vossel K. Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms. Front Aging Neurosci 2022;14:903973. [DOI: 10.3389/fnagi.2022.903973] [Reference Citation Analysis]
4 Aourz N, Van Leuven F, Allaoui W, Van Eeckhaut A, De Bundel D, Smolders I. Unraveling the Effects of GSK-3β Isoform Modulation against Limbic Seizures and in the 6 Hz Electrical Kindling Model for Epileptogenesis. ACS Chem Neurosci 2022;13:796-805. [PMID: 35253420 DOI: 10.1021/acschemneuro.1c00782] [Reference Citation Analysis]
5 Mulroe F, Lin W, Scott CM, Aourz N, Fan YN, Coutts G, Parrish RR, Smolders I, Trevelyan A, Wykes R, Allan S, Freeman S, Baines RA. Targeting neuronal homeostasis to prevent seizures.. [DOI: 10.1101/2022.03.07.483229] [Reference Citation Analysis]
6 Gwedela MNV, Terai H, Lampiao F, Matsunami K, Aizawa H. Anti-seizure effects of medicinal plants in Malawi on pentylenetetrazole-induced seizures in zebrafish larvae. J Ethnopharmacol 2022;284:114763. [PMID: 34688800 DOI: 10.1016/j.jep.2021.114763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Arciniegas Ruiz SM, Eldar-finkelman H. Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward. Front Mol Neurosci 2022;14:792364. [DOI: 10.3389/fnmol.2021.792364] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
8 Reilley DJ, Arraf Z, Alexandrova AN. Contrasting Effects of Inhibitors Li+ and Be2+ on Catalytic Cycle of Glycogen Synthase Kinase-3β. J Phys Chem B 2021;125:9480-9. [PMID: 34404214 DOI: 10.1021/acs.jpcb.1c05099] [Reference Citation Analysis]
9 Wang D, Huang X, Yan L, Zhou L, Yan C, Wu J, Su Z, Huang Y. The Structure Biology of Tau and Clue for Aggregation Inhibitor Design. Protein J 2021;40:656-68. [PMID: 34401998 DOI: 10.1007/s10930-021-10017-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Gawel K, Kukula-Koch W, Banono NS, Nieoczym D, Targowska-Duda KM, Czernicka L, Parada-Turska J, Esguerra CV. 6-Gingerol, a Major Constituent of Zingiber officinale Rhizoma, Exerts Anticonvulsant Activity in the Pentylenetetrazole-Induced Seizure Model in Larval Zebrafish. Int J Mol Sci 2021;22:7745. [PMID: 34299361 DOI: 10.3390/ijms22147745] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
11 Bertoncello KT, Bonan CD. Zebrafish as a tool for the discovery of anticonvulsant compounds from botanical constituents. Eur J Pharmacol 2021;908:174342. [PMID: 34265297 DOI: 10.1016/j.ejphar.2021.174342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Baraban SC. A zebrafish-centric approach to antiepileptic drug development. Dis Model Mech 2021;14:dmm049080. [PMID: 34231838 DOI: 10.1242/dmm.049080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
13 Davies MP, Benitez R, Perez C, Jakupovic S, Welsby P, Rzepecka K, Alder J, Davidson C, Martinez A, Hayes JM. Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β. J Med Chem 2021;64:1497-509. [PMID: 33499592 DOI: 10.1021/acs.jmedchem.0c01568] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Toniolo S, Sen A, Husain M. Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease. Int J Mol Sci 2020;21:E9318. [PMID: 33297460 DOI: 10.3390/ijms21239318] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 16.0] [Reference Citation Analysis]
15 Raut D, Bhatt LK. Evolving targets for anti-epileptic drug discovery. European Journal of Pharmacology 2020;887:173582. [DOI: 10.1016/j.ejphar.2020.173582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Lin R, Jones NC, Kwan P. Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer's Disease-Related Epileptic Seizures. Int J Mol Sci 2020;21:E3676. [PMID: 32456185 DOI: 10.3390/ijms21103676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
17 Jaworski T. Control of neuronal excitability by GSK-3beta: Epilepsy and beyond. Biochim Biophys Acta Mol Cell Res 2020;1867:118745. [PMID: 32450268 DOI: 10.1016/j.bbamcr.2020.118745] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
18 Gawel K, Kukula-Koch W, Nieoczym D, Stepnik K, Ent WV, Banono NS, Tarabasz D, Turski WA, Esguerra CV. The Influence of Palmatine Isolated from Berberis sibirica Radix on Pentylenetetrazole-Induced Seizures in Zebrafish. Cells 2020;9:E1233. [PMID: 32429356 DOI: 10.3390/cells9051233] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
19 Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Peña V. GSK3β and Tau Protein in Alzheimer's Disease and Epilepsy. Front Cell Neurosci 2020;14:19. [PMID: 32256316 DOI: 10.3389/fncel.2020.00019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 18.5] [Reference Citation Analysis]
20 Ibhazehiebo K, Rho JM, Kurrasch DM. Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies. Neuropharmacology 2020;167:107988. [PMID: 32070912 DOI: 10.1016/j.neuropharm.2020.107988] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
21 Ramurthy S, Pfister KB, Boyce RS, Brown SP, Costales AQ, Desai MC, Fang E, Levine BH, Ng SC, Nuss JM, Ring DB, Shafer CM, Shu W, Subramanian S, Wagman AS, Wang H, Bussiere DE. Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors. Bioorg Med Chem Lett 2020;30:126930. [PMID: 31926786 DOI: 10.1016/j.bmcl.2019.126930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Alkorta I, Elguero J, Dardonville C, Reviriego F, Santa María D, Claramunt RM, Marín‐luna M. A theoretical and spectroscopic (NMR and IR) study of indirubin in solution and in the solid state. J Phys Org Chem 2020;33. [DOI: 10.1002/poc.4043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Jaworski T, Banach-Kasper E, Gralec K. GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration. Neural Plast 2019;2019:4209475. [PMID: 31191636 DOI: 10.1155/2019/4209475] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
24 Nieoczym D, Socała K, Gawel K, Esguerra CV, Wyska E, Wlaź P. Anticonvulsant Activity of Pterostilbene in Zebrafish and Mouse Acute Seizure Tests. Neurochem Res 2019;44:1043-55. [PMID: 30689162 DOI: 10.1007/s11064-019-02735-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
25 Lindsley CW, Abbott C, Andrews AM, Hooker JM, Zhou J. Editors' Favorites: Best of 2018. ACS Chem Neurosci 2019;10:1-4. [PMID: 30990663 DOI: 10.1021/acschemneuro.8b00717] [Reference Citation Analysis]